About 111,000 results
Open links in new tab
GSK presents positive data for AREXVY, its respiratory syncytial …
GSK touts 3-year data on RSV shot Arexvy after CDC's narrower …
GSK RSV shot 43% effective against severe disease in third year
GSK Presents Positive Data for AREXVY, Its Respiratory ... - BioSpace
GSK announces positive topline data on co-administration of AREXVY …
US FDA approves GSK’s AREXVY, the world’s first respiratory …
US FDA approves GSK’s Arexvy, the world’s first respiratory …
GSK's RSV Vaccine Offers Protection Over Three Seasons, Study …
GSK says RSV vaccine protects against disease over three seasons
- Some results have been removed